tirzepatide surpass-4 Efficacy and Safety of in Type 2 Diabetes and Obesity Management SURPASS-CVOT Published: Large Trial Confirms
Description
A role for glucagon-like peptide-1 in the central regulation of feeding
More effective is a simplification, but tirzepatide does produce larger average weight loss for most patients
The providers worth trusting are the ones who present the evidence honestly, acknowledge the limitations, and focus on the fundamentals rather than upselling additives
Regular follow-up helps detect early signs of excessive shedding
Reduction of prevalence of patients meeting the criteria for metabolic syndrome with tirzepatide: a post hoc analysis from the SURPASS Clinical Trial Program
